Ideas
Expiry dynamics could push KOSPI up intraday.
On the simultaneous KOSPI futures/options expiry day, foreign investors are holding profitable futures positions and have incentive to push the market higher to maximize gains. Despite overnight futures being modestly lower and SK Hynix ADR strength, Lee expects the KOSPI to start weak but then stabilize or turn positive during the session, with at least one upward push driven by expiry strategy.
Middle East escalation keeps crude supported.
The US-Iran conflict is intensifying after attacks on Iranian oil tankers. Lee expects the standoff to escalate further before any ceasefire because both sides need to inflict pain, and while the US is trying to tighten Iran's oil revenue without bombing storage, oil prices should remain elevated, with WTI likely marching slowly toward $100 and potentially $120 rather than spiking uncontrollably.
Funds rotate into growth memory stocks.
Even though interest rates and oil prices are rising, memory semiconductor names kept rallying because money is rotating into sectors with visible growth. SK Hynix hit a record high, Micron responded, and DRAM was strong, suggesting the memory complex—and specifically SK Hynix—is being treated as the strongest AI-hardware growth area.
Funds rotate into growth memory stocks.
If Samsung Electronics or SK Hynix pull back today because of Middle East risk, Lee would buy for the medium-to-long term because Korean semiconductor exports are not directly exposed to the Middle East conflict. He views the war issue as similar to the March war shock, making a selloff a buying opportunity in the two semiconductor leaders.
Higher rates squeeze leveraged AI datacenter borrowers.
Rising interest rates are making it harder for capital-intensive neocloud companies that must borrow to build datacenters. Lee specifically notes CoreWeave and Nebius fell on rate pressure, while cash-rich memory and CPU companies do not face the same burden.
SK Hynix dominates Samsung on HBM.
If Samsung Electronics or SK Hynix pull back today because of Middle East risk, Lee would buy for the medium-to-long term because Korean semiconductor exports are not directly exposed to the Middle East conflict. He views the war issue as similar to the March war shock, making a selloff a buying opportunity in the two semiconductor leaders.
Korean battery makers gain from China restrictions.
Korean battery makers are getting re-rated as US and European governments step up warnings and restrictions on Chinese battery makers. Institutions bought SK Innovation and Samsung SDI, and Lee sees Korea as the main beneficiary of the regulatory backlash against China.
Robot stocks draw foreign institutional inflows.
Foreigners and institutions are returning to KOSDAQ robotics names, with Robotis strong from the open and robot-related stocks topping the KOSDAQ gainers. Lee views robotics as becoming another major KOSDAQ axis supported by visible institutional and foreign inflows.
AI power shortage lifts fuel cell demand.
Doosan Fuel Cell is attracting attention as an AI-era power-shortage beneficiary after winning a large US fuel cell contract, with the fuel cell scale growing. Even its current PAFC technology, which is one generation behind SOFC, is seeing demand for on-site power generation, and Nancy Pelosi's profitable investment in Blue Energy is adding to sentiment.
HD Hyundai re-rates as refining/LNG beneficiary.
HD Hyundai is being re-rated from a shipbuilding story to an oil-refining and LNG beneficiary: it owns most of HD Hyundai Oilbank, so higher oil prices boost refining earnings; its major shipbuilding units are healthy, and Alaska/LNG project development should raise LNG carrier orders. Lee cites a 330,000 KRW target price and strong expected third-quarter operating profit growth.
Europe underbought gas before winter prices rise.
European gas prices are rising because Europe has not stocked enough gas ahead of winter. While this winter may be mild, the supply shortfall and seasonal demand are pushing gas prices higher, and Europe's lack of preparation contrasts with Korea and Japan's larger reserves.
Roche obesity deal gives Hanmi momentum.
Hanmi Pharm received a target-price upgrade after Roche licensed its muscle-loss-prevention obesity treatment. KB Securities views Hanmi as tied to Roche, and Lee expects clinical progress to bring money into the stock, though he advises waiting for clinical catalysts before chasing.
This 815 Money Talk (815머니톡) video, published September 10, 2026,
features Lee Kwon-hee
discussing EWY, BNO, WTI, SMH, MU, 000660.KS, CoreWeave, NEBIUS, 005930.KS, 096770.KS, 006400.KS, 108490.KQ, 058610.KQ, 336260.KS, 267250.KS, UNG, 128940.KS.
12 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Kwon-hee
· Tickers:
EWY,
BNO,
WTI,
SMH,
MU,
000660.KS,
CoreWeave,
NEBIUS,
005930.KS,
096770.KS,
006400.KS,
108490.KQ,
058610.KQ,
336260.KS,
267250.KS,
UNG,
128940.KS
